Lung Nodule Detection Using Ultra-long FOV PET/CT
NCT05463913
Summary
Indeterminate lung nodules (6-15mm) are frequent findings in patients undergoing chest CT scanning, but adequate follow-up imaging is currently not in place to facilitate early detection, diagnosis and decision making regarding treatment. The introduction of long Field-Of-View PET/CT scanners could make a difference in this matter due to the substantial increase in sensitivity allowing optimal image quality. Whether this new technology could provide improved detection and follow-up of indeterminate lung nodules is what we aim to explore in this study.
Eligibility
Inclusion Criteria: * able to give informed consent * signed informed consent * confirmed indeterminate lung nodule(s) of 6-15 mm in size on CT chest imaging * routine 18F-FDG PET/CT performed * scheduled for biopsy or resection of the lung nodules Exclusion Criteria: * claustrophobia * pregnant or breastfeeding * interval of at least 2 weeks between PET scan and last date of systemic anti-cancer therapy to reduce false-negative uptake in lesions * radiation therapy of the target lung nodule(s) * uncontrolled diabetes mellitus * any medical condition potentially hampering conduction of the trial
Conditions2
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT05463913